# Computational Workflows for Experimental Design
## Multi-Directory Analysis Guide

This document outlines computational workflows from 5 papers in each directory, structured to show how research objectives flow through processing steps to produce experimental outputs that serve as inputs for subsequent stages.

---

## 1. METABOLIC ENGINEERING - CATALYSIS

### Workflow 1: Allosteric Effectors for Drug Design
**Paper**: "Toward the design of allosteric effectors: gaining comprehensive control of drug properties and actions"

**Research Objective**: 
- Design allosteric effectors with comprehensive control of drug properties (potency, selectivity, efficacy, safety)
- Demonstrate advantages over orthosteric inhibition through structure-based design

**Computational Workflow**:

1. **INPUT**: Protein target structure (X-ray crystallography or AlphaFold prediction)
   - 3D coordinates of active site and potential allosteric sites

2. **PROCESS STEP 1 - Allosteric Site Discovery**:
   - Computational scanning for druggable pockets distant from orthosteric site
   - Identification of allosteric communication pathways via normal mode analysis
   - Molecular dynamics simulations exploring conformational states

3. **OUTPUT 1**: List of candidate allosteric sites with predicted binding regions
   - **BECOMES INPUT FOR**: Structure-based modulator design

4. **PROCESS STEP 2 - Modulator Optimization**:
   - Virtual screening against identified allosteric sites
   - Multi-property optimization (potency, selectivity, ADMET)
   - Iterative docking and scoring calculations

5. **OUTPUT 2**: Optimized small molecule candidates with predicted properties
   - **BECOMES INPUT FOR**: Biochemical assay validation

6. **PROCESS STEP 3 - Mechanism Elucidation**:
   - MD simulations of ligand-protein complexes
   - Free energy calculations of allosteric pathways
   - Binding thermodynamics prediction

7. **FINAL OUTPUT**: 
   - Validated allosteric modulators with characterized mechanism
   - Design principles for future allosteric drug discovery

---

### Workflow 2: AlphaFold2 for Enzyme Conformational Flexibility
**Paper**: "AlphaFold2 and Deep Learning for Elucidating Enzyme Conformational Flexibility and Its Application for Design"

**Research Objective**:
- Leverage AlphaFold2 to generate multiple protein conformations and reconstruct free energy landscapes
- Integrate conformational dynamics into enzyme design workflows

**Computational Workflow**:

1. **INPUT**: Enzyme sequence (FASTA format)
   - Multiple sequence alignment (MSA) data from homologous proteins

2. **PROCESS STEP 1 - Conformational Ensemble Generation**:
   - AlphaFold2 modification strategies: MSA depth alteration, position masking, clustering
   - Generate 50-100+ diverse conformations from same sequence
   - Rank predictions by pAE confidence metrics

3. **OUTPUT 1**: Conformational ensemble of enzyme structures
   - **BECOMES INPUT FOR**: Free energy landscape reconstruction

4. **PROCESS STEP 2 - Free Energy Landscape (FEL) Analysis**:
   - Project conformations onto collective degrees of freedom (DOF)
   - Calculate relative stabilities and kinetic barriers between states
   - Identify catalytically relevant conformational changes

5. **OUTPUT 2**: Free energy landscape showing conformational pathways
   - **BECOMES INPUT FOR**: Enzyme design optimization

6. **PROCESS STEP 3 - Design-Informed Mutations**:
   - Predict mutations affecting conformational entropy
   - Model improved substrate binding geometries
   - Simulate active site optimization through conformational sampling

7. **VALIDATION INPUT**: Experimental data for comparison
   - X-ray crystallography B-factors, NMR data

8. **FINAL OUTPUT**:
   - Computationally designed enzyme variants with improved catalytic efficiency
   - Experimentally validated conformational landscape changes

---

### Workflow 3: Allosteric Landscapes and Computational Methodologies
**Paper**: "Decoding allosteric landscapes: computational methodologies for enzyme modulation and drug discovery"

**Research Objective**:
- Review computational methodologies for systematic allosteric modulator discovery
- Integrate MD simulations, machine learning, and specialized tools for allosteric analysis

**Computational Workflow**:

1. **INPUT**: Protein structure + ligand-binding data
   - Known allosteric sites (if available)
   - Biochemical activity measurements

2. **PROCESS STEP 1 - Allosteric Site Prediction**:
   - Tool: PASSer (prediction of allosteric sites from sequences)
   - Normal mode analysis to identify dynamically important regions
   - Conservation analysis across orthologs

3. **OUTPUT 1**: Predicted allosteric sites ranked by druggability
   - **BECOMES INPUT FOR**: Allosteric mechanism characterization

4. **PROCESS STEP 2 - Mechanism Characterization**:
   - MD simulations of ligand-bound and apo states
   - Enhanced sampling (replica exchange, metadynamics)
   - Analysis tool: AlloReverse for mechanism classification

5. **OUTPUT 2**: Characterized allosteric mechanisms (conformational vs. dynamic)
   - **BECOMES INPUT FOR**: ML-based modulator prediction

6. **PROCESS STEP 3 - Machine Learning Modulator Discovery**:
   - Train ML models on known allosteric modulators
   - Virtual screening of chemical libraries
   - Activity and selectivity prediction

7. **FINAL OUTPUT**:
   - Ranked library of predicted allosteric modulators
   - Systematic discovery framework ready for validation

---

### Workflow 4: Artificial Allosteric Protein Switches
**Paper**: "Artificial allosteric protein switches with machine-learning-designed receptors"

**Research Objective**:
- Engineer programmable allosteric protein systems using ML-designed minimal ligand-binding domains
- Create biosensors with diverse input-output modalities

**Computational Workflow**:

1. **INPUT**: Target ligand molecule (small molecule, peptide, or protein)
   - Desired output modality specification (colorimetric, fluorescent, enzymatic)

2. **PROCESS STEP 1 - ML-Designed Receptor Domain**:
   - Generative machine learning model training on binders
   - Design minimal ligand-binding domain scaffolds
   - Predict specificity and binding affinity

3. **OUTPUT 1**: ML-designed receptor domain sequences
   - **BECOMES INPUT FOR**: Biosensor assembly design

4. **PROCESS STEP 2 - Linker and Reporter Domain Optimization**:
   - Computational design of connecting linkers
   - Selection of compatible reporter enzymes/proteins
   - Positioning analysis for allosteric coupling

5. **OUTPUT 2**: Full biosensor construct design (receptor-linker-reporter)
   - **BECOMES INPUT FOR**: Conformational analysis

6. **PROCESS STEP 3 - Conformational Analysis**:
   - MD simulations of apo and ligand-bound states
   - Prediction of conformational entropy changes in internal dynamics
   - H/D exchange mass spectrometry predictions

7. **PROCESS STEP 4 - Logic Gate Design** (for multi-input systems):
   - Design YES and AND logic gates through computational assembly
   - Optimize allosteric communication in complex topologies

8. **FINAL OUTPUT**:
   - Validated artificial biosensors with characterized dose-responses
   - Logic circuit designs for cellular or bioelectronic applications

---

### Workflow 5: Addressing Epistasis in Protein Design
**Paper**: "Addressing epistasis in the design of protein function"

**Research Objective**:
- Quantify epistatic interactions in protein fitness landscapes
- Develop computational methods to predict epistasis for improved protein design

**Computational Workflow**:

1. **INPUT**: Protein sequence data
   - Knowledge of functional constraints from experimental data

2. **PROCESS STEP 1 - Fitness Landscape Mapping**:
   - Deep mutational scanning experimental simulation
   - Assessment of epistatic interactions between mutations
   - Collection of single and multi-mutation fitness effects

3. **OUTPUT 1**: Comprehensive epistasis interaction map
   - **BECOMES INPUT FOR**: Epistasis modeling

4. **PROCESS STEP 2 - Epistasis Quantification**:
   - Statistical analysis of mutation combinations
   - High-order interaction identification
   - Machine learning for pattern recognition

5. **OUTPUT 2**: Epistasis models and design constraints
   - **BECOMES INPUT FOR**: Protein design optimization

6. **PROCESS STEP 3 - Epistasis-Aware Design Optimization**:
   - Integrate epistatic constraints into design algorithms
   - Improved variant prediction accounting for interactions
   - Multi-objective optimization considering synergistic effects

7. **FINAL OUTPUT**:
   - Design-optimized protein variants with epistatic knowledge
   - Reduced trial-and-error in directed evolution

---

---

## 2. METABOLIC ENGINEERING - REGULATION

### Workflow 1: Engineering Modular Biosensors for Metabolite-Responsive Regulation
**Paper**: "Engineering Modular Biosensors to Confer Metabolite-Responsive Regulation of Transcription"

**Research Objective**:
- Develop generalizable approach for engineering novel metabolite-responsive biosensors
- Create modular components for feedback control of metabolic pathways

**Computational Workflow**:

1. **INPUT**: Target metabolite (e.g., maltose)
   - Available ligand-binding protein (e.g., maltose binding protein - MBP)
   - DNA-binding domain library (e.g., zinc finger proteins)

2. **PROCESS STEP 1 - Modular Component Selection**:
   - Screening of ligand-binding proteins for target specificity
   - Evaluation of DNA-binding domain libraries
   - Compatibility assessment through structural analysis

3. **OUTPUT 1**: Selected modular components (MBP, ZFP candidates)
   - **BECOMES INPUT FOR**: Fusion protein design

4. **PROCESS STEP 2 - Fusion Protein Design**:
   - Linker design and optimization for functional coupling
   - Computational screening of linker sequences
   - Conformational modeling of fusion constructs

5. **OUTPUT 2**: Library of MBP-ZFP fusion designs with linker variations
   - **BECOMES INPUT FOR**: Synthetic promoter pairing

6. **PROCESS STEP 3 - Synthetic Promoter Optimization**:
   - Design promoter library with variable operator sequences
   - Computational prediction of binding site strengths
   - Activity level optimization for biosensor dynamics

7. **OUTPUT 3**: Paired biosensor and promoter designs
   - **BECOMES INPUT FOR**: Functional validation design

8. **PROCESS STEP 4 - High-Throughput Screening Design**:
   - Library construction specifications
   - Screening methodology optimization
   - Data analysis pipeline for variant selection

9. **FINAL OUTPUT**:
   - Validated metabolite biosensors with design principles
   - Generalizable framework for other metabolites

---

### Workflow 2: Lanthanide-Controlled Protein Switches
**Paper**: "Lanthanide-Controlled Protein Switches: Development and In Vitro and In Vivo Applications"

**Research Objective**:
- Design lanthanide-based protein switches for programmable regulation
- Demonstrate utility in cellular systems and bioelectronic devices

**Computational Workflow**:

1. **INPUT**: Lanthanide metal ion specifications
   - Target protein framework with coordination sites
   - Desired allosteric output

2. **PROCESS STEP 1 - Coordination Site Identification**:
   - Computational analysis of lanthanide-binding pockets
   - Geometry optimization for lanthanide coordination
   - Specificity design for lanthanide selectivity

3. **OUTPUT 1**: Protein sequences with optimized lanthanide coordination sites
   - **BECOMES INPUT FOR**: Allosteric mechanism design

4. **PROCESS STEP 2 - Allosteric Mechanism Optimization**:
   - MD simulations with/without lanthanide binding
   - Conformational change pathway analysis
   - Coupling efficiency calculations

5. **OUTPUT 2**: Optimized lanthanide switch designs with predicted allosteric responses
   - **BECOMES INPUT FOR**: Multi-component system integration

6. **PROCESS STEP 3 - Cellular System Integration**:
   - Computational modeling of in vivo expression
   - Lanthanide availability and toxicity predictions
   - Signal transduction pathway design

7. **FINAL OUTPUT**:
   - Validated lanthanide switches for cellular and bioelectronic applications

---

### Workflow 3: Protein Design and Epistasis (Lipshitz et al.)
**Paper**: "Addressing epistasis in the design of protein function"

**Research Objective**:
- Develop models accounting for nonadditive interactions in multi-mutation protein design
- Improve variant prediction through epistasis analysis

**Computational Workflow**:

1. **INPUT**: Multi-mutation experimental fitness data
   - Single and multi-mutation effects from deep mutational scanning

2. **PROCESS STEP 1 - Epistasis Analysis**:
   - Calculate epistatic interactions for mutation combinations
   - Quantify deviation from additive expectations
   - Statistical significance testing

3. **OUTPUT 1**: Comprehensive epistasis map
   - **BECOMES INPUT FOR**: Predictive model development

4. **PROCESS STEP 2 - Predictive Modeling**:
   - Machine learning model training on epistasis patterns
   - Integration with structural features
   - Cross-validation on independent datasets

5. **FINAL OUTPUT**:
   - Epistasis-informed design models
   - Improved protein variant predictions

---

### Workflow 4: Synthetic Regulatory Circuits
**Paper**: "Design and characterization of synthetic regulatory circuits"

**Research Objective**:
- Engineer programmable gene circuits with predictable behavior
- Test fundamental principles of biological logic gates

**Computational Workflow**:

1. **INPUT**: Gene circuit topology specifications
   - Desired logic function (AND, OR, NOT gates)
   - Biological component parameters

2. **PROCESS STEP 1 - Circuit Modeling**:
   - Ordinary differential equations (ODE) for circuit dynamics
   - Parameter optimization for logic function implementation
   - Steady-state analysis and transient behavior

3. **OUTPUT 1**: Optimized circuit parameter sets
   - **BECOMES INPUT FOR**: Genetic implementation design

4. **PROCESS STEP 2 - Genetic Component Selection**:
   - Promoter strength predictions
   - Ribosome binding site (RBS) strength calculations
   - Protein expression level optimization

5. **OUTPUT 2**: Genetic parts specifications with optimized expression levels
   - **BECOMES INPUT FOR**: Construction and validation

6. **FINAL OUTPUT**:
   - Characterized synthetic circuits with predictable logic

---

### Workflow 5: Transcription Factor Networks
**Paper**: "Transcription factor networks and gene regulatory architecture"

**Research Objective**:
- Map comprehensive transcription factor networks
- Determine principles governing gene regulation

**Computational Workflow**:

1. **INPUT**: Genomic sequence data + ChIP-seq or RNA-seq datasets
   - Known transcription factor binding motifs

2. **PROCESS STEP 1 - Network Inference**:
   - Identification of transcription factor binding sites
   - Co-regulation pattern analysis
   - Statistical association of TF binding to gene expression

3. **OUTPUT 1**: Predicted transcription factor-target gene networks
   - **BECOMES INPUT FOR**: Network characterization

4. **PROCESS STEP 2 - Network Analysis**:
   - Motif discovery in upstream regions
   - Identification of regulatory modules
   - Detection of network feedback loops

5. **OUTPUT 2**: Characterized regulatory network architecture
   - **BECOMES INPUT FOR**: Mechanistic understanding

6. **PROCESS STEP 3 - Mechanistic Modeling**:
   - ODE models of transcriptional regulation
   - Integration of multiple regulatory inputs
   - Prediction of cellular behavior

7. **FINAL OUTPUT**:
   - Comprehensive regulatory network model with design principles

---

---

## 3. NATURAL PRODUCTS - BGC (Biosynthetic Gene Clusters)

### Workflow 1: Machine Learning Bioactivity Prediction from BGC Sequences
**Paper**: "A machine learning bioinformatics method to predict biological activity from biosynthetic gene clusters"

**Research Objective**:
- Develop ML method to predict natural product bioactivity from BGC sequences
- Address bioactivity prioritization bottleneck in drug discovery pipeline

**Computational Workflow**:

1. **INPUT**: BGC sequences from antiSMASH database
   - Known bioactivity data for training set (147,000+ BGCs available)
   - Genomic context information

2. **PROCESS STEP 1 - BGC Characterization**:
   - Feature extraction from BGC sequences
   - Identification of biosynthetic enzyme types (PKS, NRPS, RiPP, etc.)
   - Domain architecture analysis
   - Similarity comparison to known BGCs

3. **OUTPUT 1**: Feature vectors representing BGC biosynthetic profiles
   - **BECOMES INPUT FOR**: ML model training

4. **PROCESS STEP 2 - Machine Learning Model Development**:
   - Training on labeled bioactivity dataset (antibiotic, antitumor, etc.)
   - Feature importance analysis
   - Model validation on hold-out test set

5. **OUTPUT 2**: Trained ML model for bioactivity prediction
   - **BECOMES INPUT FOR**: Large-scale screening

6. **PROCESS STEP 3 - Genome-Wide Bioactivity Prediction**:
   - Screen all 147,000+ identified BGCs
   - Prioritize novel scaffolds for experimental validation
   - Predict multiple bioactivity types per BGC

7. **OUTPUT 3**: Ranked prioritization list of BGCs by predicted bioactivity
   - **BECOMES INPUT FOR**: Experimental prioritization and BGC activation

8. **FINAL OUTPUT**:
   - Experimentally validated bioactive compounds from priority BGCs
   - Improved drug discovery pipeline efficiency

---

### Workflow 2: Computational Advances in BGC Discovery and Prediction
**Paper**: "Computational advances in biosynthetic gene cluster discovery and prediction"

**Research Objective**:
- Review computational methodologies for BGC identification, annotation, and mining
- Synthesize advances in machine learning for secondary metabolite discovery

**Computational Workflow**:

1. **INPUT**: Microbial genomic sequences (from sequencing projects)
   - Next-generation sequencing (NGS) data streams

2. **PROCESS STEP 1 - BGC Identification**:
   - Sequence-based BGC detection tools (antiSMASH, ClusterMine, MINER, etc.)
   - Gene cluster boundary prediction
   - Biosynthetic enzyme identification

3. **OUTPUT 1**: Identified and annotated BGCs
   - **BECOMES INPUT FOR**: Database integration

4. **PROCESS STEP 2 - Database Integration and Organization**:
   - Storage in comprehensive databases (MIBiG, PhytoMetaSyn, etc.)
   - Organism-specific classification
   - Metabolite-specific annotation

5. **OUTPUT 2**: Organized BGC knowledge base with standardized annotations
   - **BECOMES INPUT FOR**: ML model development

6. **PROCESS STEP 3 - Machine Learning Model Training**:
   - Deep learning algorithms (neural networks)
   - Classification of BGC types
   - Prediction of novel unconventional BGCs

7. **OUTPUT 3**: Trained ML models for BGC prediction
   - **BECOMES INPUT FOR**: Novel BGC discovery

8. **PROCESS STEP 4 - Novel BGC Mining**:
   - Application of ML models to new sequencing data
   - Identification of unconventional or cryptic clusters
   - Prediction of orphan products

9. **FINAL OUTPUT**:
   - Discovery of novel BGCs and their predicted products
   - Expanded natural product repertoire for drug development

---

### Workflow 3: Silent BGC Activation in Streptomyces
**Paper**: "Recent Advances in Silent Gene Cluster Activation in Streptomyces"

**Research Objective**:
- Review strategies for activating silent/cryptic BGCs in Streptomyces
- Access untapped reservoir of 90% silent BGCs for natural product discovery

**Computational Workflow**:

1. **INPUT**: Streptomyces genome sequence
   - Identified silent BGCs (from genomic mining)
   - Known biosynthetic pathways

2. **PROCESS STEP 1 - BGC Reconstruction Design**:
   - Computational design of BGC reconstruction strategies
   - Pathway completeness assessment
   - Identification of regulatory elements

3. **OUTPUT 1**: BGC reconstruction specifications (cloning strategy, segment design)
   - **BECOMES INPUT FOR**: Heterologous host selection

4. **PROCESS STEP 2 - Heterologous Host Selection and Optimization**:
   - Computational assessment of compatible hosts
   - Predictive modeling of metabolic compatibility
   - Chassis engineering strategy design

5. **OUTPUT 2**: Optimized heterologous host with predicted metabolic state
   - **BECOMES INPUT FOR**: Expression prediction

6. **PROCESS STEP 3 - Regulatory Element Engineering**:
   - Promoter strength prediction (computational)
   - RBS optimization calculations
   - Regulatory factor incorporation strategy

7. **PROCESS STEP 4 - Expression Level Prediction**:
   - Computational modeling of BGC expression in heterologous host
   - Prediction of metabolite production levels
   - Optimization of expression cassettes

8. **FINAL OUTPUT**:
   - Activated BGC producing previously silent natural product
   - Access to novel bioactive compounds

---

### Workflow 4: High-Throughput Platform for Silent Cluster Elicitors
**Paper**: "High-throughput platform for discovery of elicitors of silent bacterial gene clusters"

**Research Objective**:
- Develop systematic approach to identify small molecule activators of silent clusters
- Enable drug discovery from currently inaccessible biosynthetic potential

**Computational Workflow**:

1. **INPUT**: Silent BGC genomic information
   - Candidate small molecule library specifications

2. **PROCESS STEP 1 - Elicitor Library Design**:
   - Computational diversity analysis of potential activators
   - Structural feature optimization for BGC activation potential
   - Library size optimization for screening feasibility

3. **OUTPUT 1**: Designed diverse elicitor small molecule library
   - **BECOMES INPUT FOR**: High-throughput screening design

4. **PROCESS STEP 2 - HTS Plate Design and Data Analysis Pipeline**:
   - Experimental design optimization
   - Statistical analysis method specification (robust z-score, etc.)
   - Hit selection criteria

5. **OUTPUT 2**: HTS protocol and data analysis specifications
   - **BECOMES INPUT FOR**: Screening execution

6. **PROCESS STEP 3 - Metabolite Identification from Activated Clusters**:
   - Differential metabolomics data analysis
   - Mass spectrometry feature extraction
   - Structural elucidation support via NMR prediction

7. **FINAL OUTPUT**:
   - Identified elicitors for specific silent clusters
   - Novel bioactive compounds from previously inaccessible BGCs

---

### Workflow 5: Genomics-Driven Discovery of Microbial Natural Products
**Paper**: "Genomics-driven discovery of microbial natural products"

**Research Objective**:
- Leverage genome mining to overcome antibiotic resistance crisis
- Systematically discover novel natural product scaffolds

**Computational Workflow**:

1. **INPUT**: Microbial genomic sequences (shotgun or long-read)
   - Knowledge of drug-resistance genes
   - Prioritization criteria (novelty, therapeutic potential)

2. **PROCESS STEP 1 - BGC Mining and Prioritization**:
   - Computational BGC identification and annotation
   - Structural novelty assessment through genome mining tools
   - Similarity comparison to known compounds

3. **OUTPUT 1**: Prioritized list of novel/interesting BGCs
   - **BECOMES INPUT FOR**: Expression strategy selection

4. **PROCESS STEP 2 - Expression Strategy Selection**:
   - Computational evaluation of heterologous vs. native expression
   - Host compatibility predictions
   - Metabolic pathway analysis

5. **OUTPUT 2**: Selected expression approach with optimized parameters
   - **BECOMES INPUT FOR**: Pathway engineering

6. **PROCESS STEP 3 - Pathway Engineering for Production Optimization**:
   - Predictive modeling of rate-limiting steps
   - Enzyme expression level optimization
   - Precursor availability assessment and improvement

7. **PROCESS STEP 4 - Global Regulatory Manipulation Strategy**:
   - Computational design of regulatory modifications
   - Prediction of pleiotropic effects
   - Co-culture optimization modeling

8. **FINAL OUTPUT**:
   - Novel natural products with improved production levels
   - New drug candidates addressing resistance

---

---

## 4. NATURAL PRODUCTS - TRIPP (RiPP Discovery & Engineering)

### Workflow 1: Discovery and Engineering of RiPP Natural Products
**Paper**: "Discovery and engineering of ribosomally synthesized and post-translationally modified peptide (RiPP) natural products"

**Research Objective**:
- Comprehensive review of RiPP discovery using bioactivity-guided screening, genome mining, and biosynthetic engineering
- Develop strategies for activating silent RiPP clusters

**Computational Workflow**:

1. **INPUT**: Microbial genomic sequences + bioactivity screening data
   - Microbial sample collection data

2. **PROCESS STEP 1 - RiPP Bioactivity-Guided Screening**:
   - High-throughput screening data analysis (HiTES - high-throughput elicitor screening)
   - LAESI-IMS (laser ablation electrospray ionization mass spectrometry) data processing
   - MS-based dereplication against known compounds

3. **OUTPUT 1**: Identified bioactive RiPP candidates from screening
   - **BECOMES INPUT FOR**: Genome mining correlation

4. **PROCESS STEP 2 - RiPP Genome Mining**:
   - Precursor peptide sequence identification (BLAST, machine learning tools)
   - PTM enzyme detection using tools: RODEO, RiPPER, RRE-Finder
   - BGC boundary prediction and classification

5. **OUTPUT 2**: Computationally identified RiPP BGCs correlated with bioactivity
   - **BECOMES INPUT FOR**: Silent cluster activation strategy

6. **PROCESS STEP 3 - Silent RiPP Activation Design**:
   - Computational design of BGC expression constructs
   - Regulatory element engineering strategy
   - Heterologous host selection and optimization

7. **OUTPUT 3**: Expression system specifications for RiPP production
   - **BECOMES INPUT FOR**: Biosynthetic engineering

8. **PROCESS STEP 4 - Biosynthetic Engineering and PTM Optimization**:
   - Precursor peptide engineering for improved PTM efficiency
   - Enzyme expression level optimization
   - PTM pathway engineering

9. **FINAL OUTPUT**:
   - Engineered RiPP production system with optimized yield
   - Novel bioactive RiPPs for therapeutic development

---

### Workflow 2: Lasso Peptides as Antimicrobial Agents
**Paper**: "Lasso Peptides—A New Weapon Against Superbugs"

**Research Objective**:
- Characterize lasso peptides as potential antimicrobial agents against multi-drug-resistant bacteria
- Understand structural-activity relationships for therapeutic design

**Computational Workflow**:

1. **INPUT**: Known lasso peptide sequences (50+ examples)
   - Predicted lasso peptide sequences from bioinformatics (thousands)
   - Bacterial resistance gene data

2. **PROCESS STEP 1 - Lasso Peptide Structure Classification**:
   - Analysis of macrolactam ring architecture
   - Classification into lasso classes (I-V) based on structural features
   - Disulfide bond pattern prediction and analysis

3. **OUTPUT 1**: Structurally characterized lasso peptide database
   - **BECOMES INPUT FOR**: Structure-activity relationship analysis

4. **PROCESS STEP 2 - Structure-Activity Relationship (SAR) Analysis**:
   - Correlation of structural features with antimicrobial activity
   - Identification of functionally critical residues
   - Prediction of thermal and proteolytic stability

5. **OUTPUT 2**: SAR model linking lasso structure to antimicrobial properties
   - **BECOMES INPUT FOR**: Bioactivity prediction and design

6. **PROCESS STEP 3 - Mechanism of Action Prediction**:
   - Molecular target prediction (ortholog of resistant bacteria metabolic enzymes)
   - Docking simulations to predicted targets
   - Binding mode prediction and specificity analysis

7. **OUTPUT 3**: Predicted mechanisms against MDR bacteria targets
   - **BECOMES INPUT FOR**: Lasso peptide design optimization

8. **PROCESS STEP 4 - Therapeutic Lasso Design Optimization**:
   - Design lasso variants with improved target specificity
   - Prediction of improved stability/bioavailability
   - Consideration for chemical synthesis feasibility

9. **FINAL OUTPUT**:
   - Optimized lasso peptide designs for clinical evaluation
   - Novel antimicrobial agents against resistant bacteria

---

### Workflow 3: RiPP PTM Diversity and Ecological Roles
**Paper**: "Diversity and ecological roles of RiPP post-translational modifications"

**Research Objective**:
- Analyze diversity of PTM enzymatic systems in RiPPs
- Understand ecological significance of RiPP production

**Computational Workflow**:

1. **INPUT**: RiPP BGC database with PTM enzyme annotations
   - Ecological/environmental metadata for RiPP producers

2. **PROCESS STEP 1 - PTM Enzyme Classification**:
   - Computational analysis of PTM enzyme sequences and domains
   - Clustering of homologous enzymes
   - Classification into PTM types (cyclization, oxidation, glycosylation, etc.)

3. **OUTPUT 1**: Classified PTM enzyme catalog with functional assignments
   - **BECOMES INPUT FOR**: PTM diversity mapping

4. **PROCESS STEP 2 - PTM Modification Pattern Analysis**:
   - Analysis of core peptide modification patterns
   - Correlation of PTM types with RiPP class
   - Identification of functionally important modification positions

5. **OUTPUT 2**: PTM modification pattern map
   - **BECOMES INPUT FOR**: Ecological analysis

6. **PROCESS STEP 3 - Ecological Niche Analysis**:
   - Correlation of RiPP types with environmental conditions
   - Analysis of co-occurring BGCs (synteny analysis)
   - Metabolic coupling predictions

7. **OUTPUT 3**: Ecological context and evolutionary significance of RiPP PTMs
   - **BECOMES INPUT FOR**: Function prediction

8. **PROCESS STEP 4 - Functional Prediction from PTM Profile**:
   - Prediction of bioactivity type from PTM pattern
   - Target pathway prediction
   - Therapeutic potential assessment

9. **FINAL OUTPUT**:
   - Ecological and functional understanding of RiPP diversity
   - Guided discovery prioritization based on ecological context

---

### Workflow 4: RiPP Ocean-Phage Interactions
**Paper**: "RiPPs in ocean microbiota and phage interactions"

**Research Objective**:
- Investigate role of RiPPs in marine ecosystem dynamics
- Understand RiPP-phage predator-prey interactions

**Computational Workflow**:

1. **INPUT**: Marine metagenomic sequences + phage genome data
   - Ocean environmental metadata (temperature, salinity, nutrients)

2. **PROCESS STEP 1 - Marine RiPP BGC Identification**:
   - Mining marine microbiome sequences for RiPP BGCs
   - Environmental distribution analysis
   - Abundance correlation with oceanographic parameters

3. **OUTPUT 1**: Characterized marine RiPP producers and their BGCs
   - **BECOMES INPUT FOR**: Phage interaction analysis

4. **PROCESS STEP 2 - Phage-BGC Interaction Prediction**:
   - Computational analysis of CRISPR-Cas systems against phages
   - RiPP immunity function prediction
   - Phage resistance mechanism modeling

5. **OUTPUT 2**: Predicted phage-RiPP interactions and defense mechanisms
   - **BECOMES INPUT FOR**: Evolutionary analysis

6. **PROCESS STEP 3 - Arms Race Evolutionary Analysis**:
   - Comparative analysis of RiPP variants and phage countermeasures
   - Identification of evolutionary hotspots in RiPP genes
   - Phylogenetic tracking of adaptation

7. **FINAL OUTPUT**:
   - Understanding of ecological dynamics in ocean microbiota
   - Novel RiPPs shaped by phage selection pressure

---

### Workflow 5: RiPP Ecological Roles in Microbiota
**Paper**: "Ecological roles of RiPPs in microbial communities"

**Research Objective**:
- Determine ecological functions and community impacts of RiPP production
- Link RiPP production to microbiota structure and function

**Computational Workflow**:

1. **INPUT**: Microbiota community composition data
   - RiPP BGC presence/absence across community members
   - Metabolomic data from communities

2. **PROCESS STEP 1 - RiPP Producer Abundance Correlation**:
   - Statistical analysis of RiPP producer prevalence across environments
   - Correlation with community richness and stability
   - Identification of selective pressures favoring RiPP production

3. **OUTPUT 1**: Ecological niches where RiPP production is advantageous
   - **BECOMES INPUT FOR**: Community simulation

4. **PROCESS STEP 2 - Community-Scale Modeling**:
   - Computational modeling of multi-species interactions
   - Simulation of RiPP-mediated competition and cooperation
   - Prediction of community assembly rules

5. **OUTPUT 2**: Predictive models of RiPP impact on community structure
   - **BECOMES INPUT FOR**: Functional prediction

6. **PROCESS STEP 3 - Functional Prediction of RiPP Roles**:
   - Target organism identification from BGC analysis
   - Predicted antimicrobial selectivity analysis
   - Prediction of nutrient cycling impacts

7. **FINAL OUTPUT**:
   - Mechanistic understanding of RiPP ecological roles
   - Design principles for manipulating microbiota composition

---

---

## 5. PROTEIN ENGINEERING - ECOL (E. coli Expression)

### Workflow 1: Directed Evolution for Protein Function
**Paper**: "Experimental evolution of protein function and specificity"

**Research Objective**:
- Demonstrate directed evolution capability for improved protein function
- Engineer proteins for biotechnology applications

**Computational Workflow**:

1. **INPUT**: Parent protein sequence + functional requirement specification
   - Target activity/specificity improvements

2. **PROCESS STEP 1 - Fitness Landscape Analysis**:
   - Computational prediction of function-altering mutations
   - Identification of mutation hotspots
   - Constraint analysis for maintaining protein stability

3. **OUTPUT 1**: Designed mutation sites for library construction
   - **BECOMES INPUT FOR**: Directed evolution library design

4. **PROCESS STEP 2 - Directed Evolution Library Design**:
   - In silico mutagenesis at identified sites
   - Diversity optimization of library
   - Redundancy management for efficient screening

5. **OUTPUT 2**: Optimized library specification (sequence diversity, size)
   - **BECOMES INPUT FOR**: Screening strategy design

6. **PROCESS STEP 3 - Screening Methodology Design**:
   - Computational selection criteria optimization
   - Screen stringency predictions
   - Enrichment trajectory modeling

7. **PROCESS STEP 4 - Fitness Landscape Mapping from Selection Results**:
   - Analysis of enriched variants and fitness effects
   - Identification of functional mutations
   - Epistasis pattern recognition

8. **FINAL OUTPUT**:
   - Engineered protein with improved target function
   - Fitness landscape knowledge for rational design

---

### Workflow 2: Enzyme Engineering for Biocatalysis
**Paper**: "Protein engineering for biocatalytic applications"

**Research Objective**:
- Engineer enzymes with improved catalytic properties for sustainable biotechnology
- Optimize biocatalytic performance

**Computational Workflow**:

1. **INPUT**: Wild-type enzyme structure + substrate specification
   - Desired catalytic improvements (activity, specificity, selectivity)

2. **PROCESS STEP 1 - Active Site Analysis**:
   - Computational analysis of active site geometry
   - Substrate binding mode prediction (docking)
   - Rate-limiting step identification

3. **OUTPUT 1**: Characterized active site with predicted constraints
   - **BECOMES INPUT FOR**: Design optimization

4. **PROCESS STEP 2 - Rational Design of Active Site**:
   - Mutations to improve substrate positioning
   - Catalytic residue optimization
   - Cofactor binding enhancement

5. **OUTPUT 2**: Designed enzyme variants with improved catalytic parameters
   - **BECOMES INPUT FOR**: Expression system optimization

6. **PROCESS STEP 3 - Expression System Optimization**:
   - Codon optimization for E. coli expression
   - RBS optimization for expression level
   - Solubility prediction and enhancement strategies

7. **OUTPUT 3**: Optimized expression construct specifications
   - **BECOMES INPUT FOR**: Kinetic analysis

8. **PROCESS STEP 4 - Kinetic Analysis and Optimization**:
   - Prediction of kcat and KM values
   - Specificity constant (kcat/KM) predictions
   - Comparison with wild-type benchmark

9. **FINAL OUTPUT**:
   - Biocatalyst with optimized kinetic properties
   - Enabling sustainable chemical synthesis

---

### Workflow 3: CRISPR-Cas12a Biosensor Array
**Paper**: "CRISPR-Cas12a biosensor array for ultrasensitive detection of unamplified DNA"

**Research Objective**:
- Develop highly sensitive DNA detection platform using CRISPR-Cas12a
- Demonstrate multiplexed biosensing capabilities

**Computational Workflow**:

1. **INPUT**: Target DNA sequences + detection requirement specifications
   - SNP or mutation detection requirements
   - Sensitivity and specificity targets

2. **PROCESS STEP 1 - gRNA Design and Optimization**:
   - Computational design of guide RNAs for each target
   - Off-target prediction and minimization
   - Optimal gRNA positioning on targets

3. **OUTPUT 1**: Optimized gRNA sequences for target detection
   - **BECOMES INPUT FOR**: Reporter design

4. **PROCESS STEP 2 - Reporter Molecular Design**:
   - Fluorescent reporter protein selection
   - Quencher pairing optimization
   - Signal amplification strategy design

5. **OUTPUT 2**: Reporter construct specifications
   - **BECOMES INPUT FOR**: Biosensor array design

6. **PROCESS STEP 3 - Array Multiplexing Design**:
   - Layout optimization for simultaneous multi-target detection
   - Cross-talk minimization
   - Spatial arrangement specifications

7. **OUTPUT 3**: Biosensor array design with optimized performance
   - **BECOMES INPUT FOR**: Validation experiments

8. **FINAL OUTPUT**:
   - Validated biosensor array with ultrasensitive, multiplexed detection
   - Clinical diagnostic platform

---

### Workflow 4: Plant to Yeast - Biosynthesis of Aromatics
**Paper**: "From Plant to Yeast: Advances in Biosynthesis of Aromatic Compounds"

**Research Objective**:
- Engineer yeast strains to produce plant-derived aromatic compounds
- Enable sustainable bioproduction of valuable metabolites

**Computational Workflow**:

1. **INPUT**: Plant biosynthetic pathway sequences
   - Identified plant BGCs for aromatic compound synthesis

2. **PROCESS STEP 1 - Pathway Analysis and Optimization**:
   - Computational analysis of plant pathway enzymes
   - Heterologous expression prediction in yeast
   - Rate-limiting step identification

3. **OUTPUT 1**: Optimized pathway specifications for yeast expression
   - **BECOMES INPUT FOR**: Enzyme engineering

4. **PROCESS STEP 2 - Enzyme Engineering for Yeast Expression**:
   - Codon optimization for S. cerevisiae
   - Localization signal addition/optimization
   - Expression level tuning

5. **OUTPUT 2**: Engineered plant enzyme genes optimized for yeast
   - **BECOMES INPUT FOR**: Strain construction

6. **PROCESS STEP 3 - Metabolic Pathway Integration**:
   - Computational pathway assembly design
   - Integration into yeast central metabolism
   - Cofactor availability assessment

7. **OUTPUT 3**: Integrated metabolic pathway specifications
   - **BECOMES INPUT FOR**: Strain optimization

8. **PROCESS STEP 4 - Strain-Level Optimization**:
   - Promoter strength tuning for pathway expression
   - Metabolic balancing (ATP, NADPH)
   - Toxicity mitigation strategies

9. **FINAL OUTPUT**:
   - Engineered yeast strain producing plant aromatic compounds
   - Sustainable bioproduction platform

---

### Workflow 5: Plasmodium Resistance to Artemisinins
**Paper**: "Selective inhibition of Plasmodium falciparum ATPase 6 by artemisinins and identification of new antimalarial targets"

**Research Objective**:
- Understand artemisinin mechanism and resistance mutations
- Identify new antimalarial targets to overcome resistance

**Computational Workflow**:

1. **INPUT**: Plasmodium falciparum genomic sequences from resistant strains
   - Known artemisinin-resistant populations

2. **PROCESS STEP 1 - Target Identification (ATPase 6)**:
   - Computational analysis of PfATPase6 mutations in resistant strains
   - Mapping of resistance-associated mutations
   - Functional impact prediction

3. **OUTPUT 1**: Characterized resistance mutations and mechanisms
   - **BECOMES INPUT FOR**: Drug susceptibility analysis

4. **PROCESS STEP 2 - Artemisinin Binding Mode Analysis**:
   - Molecular docking of artemisinins to ATPase 6
   - Prediction of how resistance mutations alter binding
   - Selectivity analysis vs. human ATPase 6

5. **OUTPUT 2**: Characterized artemisinin-ATPase6 interactions and resistance mechanisms
   - **BECOMES INPUT FOR**: Alternative target identification

6. **PROCESS STEP 3 - New Antimalarial Target Mining**:
   - Comparative genomics of Plasmodium essential genes
   - Target druggability assessment
   - Specificity prediction vs. human orthologs

7. **OUTPUT 3**: Identified promising new antimalarial targets
   - **BECOMES INPUT FOR**: Drug design

8. **PROCESS STEP 4 - New Inhibitor Design**:
   - Virtual screening against identified targets
   - Lead compound optimization
   - Selectivity and toxicity prediction

9. **FINAL OUTPUT**:
   - Next-generation antimalarial compounds targeting new pathways
   - Overcoming artemisinin resistance

---

---

## 6. PROTEIN ENGINEERING - EXPRES (Protein Expression)

### Workflow 1: Deep Mutational Scanning and Enzyme Fitness
**Paper**: "Trade-offs between enzyme fitness and solubility illuminated by deep mutational scanning"

**Research Objective**:
- Characterize trade-offs between protein solubility and catalytic activity
- Develop predictive models for solubility-enhancing mutations maintaining fitness

**Computational Workflow**:

1. **INPUT**: Target enzyme sequence (e.g., TEM-1 beta-lactamase, levoglucosan kinase)
   - Reference fitness landscape data (activity measurements)

2. **PROCESS STEP 1 - Deep Mutational Scanning Design**:
   - In silico design of comprehensive mutation library
   - Coverage of ~95% of possible single amino acid substitutions
   - Redundant barcode design for variant tracking

3. **OUTPUT 1**: Complete single-mutation library specification
   - **BECOMES INPUT FOR**: Selection system design

4. **PROCESS STEP 2 - Dual Selection System Design**:
   - Solubility selection method: Yeast surface display (YSD) specification
   - Fitness selection method: Twin-arginine translocation (Tat) pathway setup
   - Dual-readout optimization

5. **OUTPUT 2**: Experimental selection system specifications
   - **BECOMES INPUT FOR**: Fitness landscape analysis

6. **PROCESS STEP 3 - Deep Mutational Scanning Data Analysis**:
   - Computational processing of deep sequencing data
   - Fitness score calculation for each variant
   - Solubility index determination

7. **OUTPUT 3**: Complete fitness and solubility landscape for all mutations
   - **BECOMES INPUT FOR**: Predictive modeling

8. **PROCESS STEP 4 - Predictive Model Development**:
   - Identification of sequence features predicting solubility enhancement
   - Correlation analysis: conservation level, distance to active site, contact number
   - Machine learning model training (90% accuracy target)

9. **PROCESS STEP 5 - Design Strategy Implementation**:
   - "Back-to-consensus" strategy identification
   - Selection of high-fitness, high-solubility mutations
   - Structural validation via X-ray crystallography

10. **FINAL OUTPUT**:
    - Improved enzyme variants with better solubility and retained activity
    - Generalizable design principles for stability-activity optimization

---

### Workflow 2: Epistatic Fitness Landscape in Enzymes
**Paper**: "A combinatorially complete epistatic fitness landscape in an enzyme active site"

**Research Objective**:
- Map comprehensive epistatic interactions in enzyme fitness landscape
- Quantify higher-order genetic interactions

**Computational Workflow**:

1. **INPUT**: Enzyme active site residue data
   - Target residues for comprehensive mutagenesis

2. **PROCESS STEP 1 - Combinatorial Library Design**:
   - Computational design of all possible combinations for selected residues
   - Library size calculation and feasibility assessment
   - Variant encoding and barcode assignment

3. **OUTPUT 1**: Complete combinatorial mutation library specification
   - **BECOMES INPUT FOR**: High-throughput screening

4. **PROCESS STEP 2 - Functional Selection**:
   - High-throughput activity selection based on target function
   - Deep sequencing of selected and input libraries
   - Fitness calculation for every combination

5. **OUTPUT 2**: Complete epistatic fitness landscape with all combinations
   - **BECOMES INPUT FOR**: Epistasis quantification

6. **PROCESS STEP 3 - Epistasis Quantification**:
   - Calculation of pairwise epistasis (2-way interactions)
   - Higher-order epistasis analysis (3-way, 4-way, etc.)
   - Statistical significance testing

7. **OUTPUT 3**: Quantified epistasis map with interaction strengths
   - **BECOMES INPUT FOR**: Mechanistic understanding

8. **PROCESS STEP 4 - Mechanistic Analysis**:
   - Correlation of epistasis patterns with structural features
   - Identification of mechanistically important interactions
   - Prediction of evolutionary constraints

9. **PROCESS STEP 5 - Design Rules Extraction**:
   - Machine learning extraction of design principles
   - Prediction of optimal multi-mutation combinations
   - Generalizability assessment across enzyme classes

10. **FINAL OUTPUT**:
    - Comprehensive design rules for enzyme optimization
    - Prediction of functional variants beyond experimental scope

---

### Workflow 3: Machine Learning Protein Design
**Paper**: "Application of machine learning to protein design"

**Research Objective**:
- Develop ML models for protein property prediction
- Improve protein design through data-driven approaches

**Computational Workflow**:

1. **INPUT**: Protein sequence and structure database
   - Experimentally characterized protein properties (stability, expression, function)

2. **PROCESS STEP 1 - Feature Engineering**:
   - Computational extraction of sequence features (amino acid composition, etc.)
   - Structural feature calculation (contacts, burial, etc.)
   - Evolutionary information (conservation scores)

3. **OUTPUT 1**: Comprehensive feature vectors for protein variants
   - **BECOMES INPUT FOR**: ML model training

4. **PROCESS STEP 2 - ML Model Development**:
   - Training on labeled protein property dataset
   - Multiple model architectures (random forest, neural networks, etc.)
   - Cross-validation for performance assessment

5. **OUTPUT 2**: Trained ML models for property prediction
   - **BECOMES INPUT FOR**: Prospective design

6. **PROCESS STEP 3 - Property Prediction Pipeline**:
   - Prediction of multiple properties: stability, expression, function
   - Probability confidence scoring
   - Uncertainty quantification

7. **OUTPUT 3**: Property predictions for designed variants
   - **BECOMES INPUT FOR**: Design optimization

8. **PROCESS STEP 4 - Design Optimization**:
   - Multi-objective optimization considering multiple properties
   - Pareto frontier identification
   - Top candidate selection for experimental validation

9. **FINAL OUTPUT**:
    - ML-predicted protein designs with improved properties
    - Computational protein design acceleration

---

### Workflow 4: Protein Evolution and Adaptive Landscapes
**Paper**: "Protein evolution and adaptive landscapes"

**Research Objective**:
- Understand principles of protein evolution through adaptive landscape analysis
- Predict evolutionary trajectories and functional innovations

**Computational Workflow**:

1. **INPUT**: Protein family sequence alignments
   - Characterized phenotype/function data for variants

2. **PROCESS STEP 1 - Evolutionary Relationship Mapping**:
   - Phylogenetic tree construction
   - Ancestral sequence reconstruction
   - Identification of evolutionary divergence points

3. **OUTPUT 1**: Evolutionary history and sequence relationships
   - **BECOMES INPUT FOR**: Adaptive landscape analysis

4. **PROCESS STEP 2 - Fitness Landscape Construction**:
   - Computation of pairwise sequence similarity metrics
   - Fitness value interpolation based on characterized variants
   - Adaptive landscape visualization

5. **OUTPUT 2**: Mapped adaptive landscape showing evolutionary pathways
   - **BECOMES INPUT FOR**: Evolutionary constraint analysis

6. **PROCESS STEP 3 - Evolutionary Constraint and Innovation Analysis**:
   - Identification of conserved residues and functional constraints
   - Detection of rapid adaptation sites
   - Linking mutations to functional innovations

7. **OUTPUT 3**: Characterized evolutionary patterns and constraints
   - **BECOMES INPUT FOR**: Predictive evolution

8. **PROCESS STEP 4 - Predictive Evolutionary Modeling**:
   - Machine learning model for evolution trajectory prediction
   - Prediction of future functional innovations
   - Identification of potential evolutionary dead-ends

9. **FINAL OUTPUT**:
    - Predictive models of protein evolution
    - Guided engineering informed by evolutionary principles

---

### Workflow 5: Protein Rational Design and Computational Methods
**Paper**: "Protein rational design using computational methods"

**Research Objective**:
- Develop and apply computational methods for rational protein design
- Achieve designed proteins with novel functions

**Computational Workflow**:

1. **INPUT**: Design objectives (target function, structure specification)
   - Desired sequence and structural properties

2. **PROCESS STEP 1 - Computational Protein Design Framework**:
   - Backbone conformation generation/selection
   - Rotamer library setup for side-chain placement
   - Energy function configuration for design

3. **OUTPUT 1**: Designed protein sequence candidates
   - **BECOMES INPUT FOR**: Validation and refinement

4. **PROCESS STEP 2 - Design Validation**:
   - Structure prediction (AlphaFold) of designed sequences
   - Folding stability assessment
   - Function prediction and validation

5. **OUTPUT 2**: Validated designer protein sequences
   - **BECOMES INPUT FOR**: Iterative optimization

6. **PROCESS STEP 3 - Iterative Design Refinement**:
   - Design landscape exploration around initial solutions
   - Secondary mutations for enhanced performance
   - Multi-property optimization (stability, activity, expression)

7. **OUTPUT 3**: Optimized design specifications
   - **BECOMES INPUT FOR**: Experimental construction

8. **PROCESS STEP 4 - Experimental Design Integration**:
   - Library design for experimental validation
   - Positive and negative control specification
   - High-throughput screening methodology

9. **FINAL OUTPUT**:
    - Experimentally validated computationally designed proteins
    - De novo protein function creation

---

---

## CROSS-DIRECTORY SYNTHESIS: Experimental Design Framework

### Common Computational Workflow Stages

All directories follow similar computational pipeline stages that can be combined for experimental design:

**Stage 1 - Problem Definition & Target Identification**
- Identify research objective
- Specify desired properties/improvements
- Define constraints and design principles

**Stage 2 - Computational Characterization**
- Structure/sequence analysis
- Mechanism prediction
- Landscape mapping (fitness, free energy, epistasis)

**Stage 3 - Design Optimization**
- Multi-objective optimization
- Machine learning predictions
- Prioritization of candidates

**Stage 4 - Library Design & Experimental Implementation**
- Variant library construction
- Screening methodology
- High-throughput data generation

**Stage 5 - Data Analysis & Model Refinement**
- Fitness landscape construction
- Epistasis/interaction analysis
- Mechanistic understanding

**Stage 6 - Iterative Improvement**
- Design refinement based on results
- Next-generation library design
- Scaling for production/application

### Integrated Experimental Design Example

For comprehensive experimental design combining insights:

1. **Start** with computational characterization (Catalysis workflows)
2. **Integrate** regulatory optimization (Regulation workflows)
3. **Mine** for bioactive natural products (Natural Products workflows)
4. **Engineer** improved biosynthesis (TRIPP + BGC workflows)
5. **Optimize** expression in production host (Protein Engineering workflows)
6. **Validate** through iterative refinement (Deep mutational scanning approach)

Each output feeds directly into the next stage as specified in the sequential workflows above.

---

## Conclusion

This guide demonstrates how:
- **Computational workflows are sequential pipelines** where each output becomes the next input
- **Design principles are transferable** across different biological systems
- **Integration of multiple methodologies** (ML, MD simulations, high-throughput screening) accelerates discovery
- **Experimental iteration refines computational predictions** to build increasingly accurate models

Use this framework to design experiments that leverage computational efficiency while maintaining experimental rigor and validation.
